Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
Autor: | McNamara, Blair, Greenman, Michelle, Bellone, Stefania, Santin, Luca A., Demirkiran, Cem, Mutlu, Levent, Hartwich, Tobias Max Philipp, Yang-Hartwich, Yang, Ratner, Elena, Schwartz, Peter E., Santin, Alessandro D. |
---|---|
Zdroj: | In Gynecologic Oncology October 2024 189:16-23 |
Databáze: | ScienceDirect |
Externí odkaz: |